Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02438007
Title A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC
Recruitment Terminated
Gender male
Phase Phase III
Variant Requirements No
Sponsors Tokai Pharmaceuticals
Indications

prostate cancer

Therapies

Galeterone

Enzalutamide

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL


No variant requirements are available.